Scientific Summits conference — Tervuren, 5 & 6 May 2023

We had the honour and the pleasure to invite you to our first Scientific Summits conference of 2023, which will take place on Friday 5 & Saturday 6 May in The Royal Museum for Central Africa.

TOP SPEAKERS, TOP CONTENT

We are proud to once again offer a top scientific program, with excellent Belgian and international key opinion leaders. The program combines case-based discussions and interactive overviews of important novelties in the field of urothelial, prostate and kidney cancer.

Friday 5 & Saturday 6 May 2023

Live meeting

The Royal Museum for Central Africa

Leuvensesteenweg 13, 3080 Tervuren

23/V2/13329/008631

Program – Scientific Summits

Friday 5 May 2023
12h30-13h30
Lunch and WELCOME
13h30-14h15
Non muscle-invasive bladder cancer
13h30 – 13h45
Place of photodynamic surgery

Speaker: Prof. Dr. Paolo Gontero, University of Studies, Torino, Italy

13h45-14h00
How to perform the best quality TURBT?

Speaker: Associate Prof. Lorenzo Tosco, Hôpital Universitaire de Bruxelles

14h00-14h15
Q&A

Panel:

Dr. Grégoire Assenmacher, Europe Hospitals, Uccle
Dr Lieven Goeman, AZ Delta Roeselare
Prof. Dr. Paolo Gontero, University of Studies, Torino, Italy

14h15 – 15h45
Muscle-invasive bladder cancer and upper urinary tract tumors
14h15-14h40
Orthotopic versus abdominal urinary diversion: what to choose for which patient ?

Speaker: Prof. Dr. Karel Decaestecker, AZ Maria Middelares Gent

14h40-15h05
Adjuvant treatment after cystectomy: what you should know for your MOC

a. The Data

Speaker: Prof. Dr. Christof Vulsteke AZ Maria Middelares Gent

b. The Belgian reimbursement rules

Speaker: Dr. Thomas Meyskens, AZ Klina Brasschaat

15h05-15h30
Adjuvant treatment after surgery for upper urinary tract tumors: what you should know for your MOC

a. The Data

Speaker: Prof Dr Tom Powles – Barts Cancer Centre, London

b. The Belgian reimbursement rules

Speaker: Dr. Thomas Meyskens, AZ Klina Brasschaat

15h30-15h45
Q&A

Panel:

Dr. Grégoire Assenmacher, Europe Hospitals, Uccle
Prof. Dr. Karel Decaestecker, AZ Maria Middelares Gent
Dr. Thomas Meyskens, AZ Klina Brasschaat
Prof. Dr. Christof Vulsteke AZ Maria Middelares Gent

15h45-16h15
Coffee break
16h15-17h30
Kidney cancer
16h15-16h40
Optimal imaging for different histological tumor types

Speaker: Dr. Filip Claus, OLV Aalst

16h40-17h10
Adjuvant treatment after (partial) nephrectomy: what you should know for your MOC

a. The data

Speaker: Prof Dr Tom Powles – Barts Cancer Centre, London

b. The Belgian reimbursement rules

Speaker: Dr. Thomas Meyskens, AZ Klina Brasschaat

17h10-17h30
What is new in Belgian research?

Speaker: Prof. Dr. Karel Decaestecker, AZ Maria Middelares Gent

17h30-17h45
Q&A

Panel:

Dr. Filip Claus, OLV Aalst
Prof. Dr. Karel Decaestecker, AZ Maria Middelares Gent
Prof. Dr. Christof Vulsteke AZ Maria Middelares  Gent
Dr. Thomas Meyskens, AZ Klina Brasschaat

17h45-18h15
Mini Symposium by Pfizer/Merck
18h15-19h00
NETWORKING RECEPTION
19h00
DINNER
Saturday 6 May 2023
09h30-12h30
Prostate cancer
09h30-10h00
A positive multi-parametric MRI: how to biopsy?

a. Only the dominant lesion

Speaker: Prof. Dr. Jochen Walz, Institut Paoli-Calmettes Cancer Centre, Marseille, France

b. The dominant lesion and random biopsies

Speaker: Prof. Dr. Steven Joniau, UZ Leuven

10h00-10h10
Q&A

Panel:

Prof. Dr. Benedikt Engels, AZ Delta Roeselare
Prof. Dr. Thomas Gevaert, AZ Klina Brasschaat, & UZ Leuven
Prof. Dr. Tobias Maurer, Martini-Klinik, Hamburg, Germany
Prof. Dr. Jochen Walz, Institut Paoli-Calmettes Cancer Centre, Marseille, France

10h10-10h30
Primary staging for prostate cancer: when do we need a PSMA?

Speaker: Prof. Dr. Tobias Maurer, Martini-Klinik, Hamburg, Germany

10h30-10h45
Q&A

Panel:

Prof. Dr. David Dearnaley, Royal Marsden Hospital, London, UK
Prof. Dr. Benedikt Engels, AZ Delta Roeselare
Prof. Dr. Steven Joniau, UZ Leuven
Prof. Dr. Charles Van Praet, UZ Gent
Prof. Dr. Jochen Walz, Institut Paoli-Calmettes Cancer Centre, Marseille, France

10h45-11h10
COFFEE BREAK
11h10-11h30
Is adjuvant radiotherapy after radical prostatectomy really “dead”?

Speaker: Prof. Dr. David Dearnaley, Royal Marsden Hospital, London, UK

11h30-11h40
Q&A

Panel:

Prof. Dr. Benedikt Engels, AZ Delta, Roeselare
Prof. Dr. Steven Joniau, Leuven University Hospitals
Prof. Dr. Tobias Maurer, Martini-Klinik Prostate Cancer Center, University of Hamburg-Eppendorf, Germany
Prof. Dr. Charles Van Praet, University Hospital Gent
Prof. Dr. Jochen Walz, Institut Paoli-Calmettes Cancer Centre, Marseille, France

11h40-12h10
What is new in Belgian research?
The phase 2 MEDCARE trial: mature results

Speaker: Dr. Kato Rans, Leuven University Hospitals

Predictors of recurrence after metastasis-directed therapy in oligorecurrent prostate cancer following radical prostatectomy

Speaker: Dr. Uros Milenkovic, Leuven University Hospitals

12h10-12h30
Q&A and closing remarks

Panel:

Prof. Dr. David Dearnaley, Radiation Oncology, Royal Marsden Hospital, London
Prof. Dr. Gert De Meerleer, UZ Leuven
Prof. Dr. Steven Joniau, UZ Leuven
Prof. Dr. Tobias Maurer, Martini-Klinik, Hamburg, Germany

12h30
LUNCH

Thanks to our sponsors

Diamond sponsor

Gold sponsor

GOLD

Silver sponsor

Silver

Bronze sponsor

BRONZE